NLRC4 and macrophage activation syndrome: Indeed, clinical trials that investigate the effects of IL-18BP treatment for AOSD and NLRC4-associated MAS were previously performed (ClinicalTrials.gov Identifier: NCT02398435, NCT03113760) [37,38].